EtizolamChronic subdural hematoma (CSDH)middle meningeal artery (MMA) embolization
…%). Six had recurrent CSDH post-surgery; nine had primary CSDH. Etizolam dosage was titrated to 1 mg (n=8), 2 mg (n=5), 3 mg (n=2) as to…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 841–900 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
HFNO4Impella4MRTX11334Metoclopramide4Midodrine4NA4Pravastatin4Risperidone4Surfactant4chlorhexidine4intravenous morphine4ENDS4Epcoritamab4FLT3L4Febuxostat4Pertuzumab4TIraGolumab4anti-PD-14topotecan4AED4Dapirolizumab pegol4Mesalamine4Peptides4S-Ketamine4Valsalva4cefazolin4fosfomycin4gabapentinoid4siltuximab4zimberelimab4AC4Budesonide orodispersible tablets4CAR-T4Chemsex4Enalapril4G-CSF4GHB/GBL4IFN-β4Isoprenaline4Methacholine4PD-14Talimogene laherparepvec4cholecalciferol4glucagon4nicotine pouches40.25% bupivacaine4ART4Anti-centromere4Comaneci4DMTs4GCs4ICG4IL-174IV methylprednisolone4Ivabradine4Loop diuretics4Natriuretic Peptide4Nitrofurantoin4PE4Ribavirin4
Articles mentioning drugs
10,506 articles · page 154 of 876eTICI 2b-3eTICIischemic strokeNational Institute of Neurological Disorders and StrokeAmerican Heart Association GWTG-Stroke ProgramthrombectomyNIH StrokeNet Training Program
…Introduction Successful reperfusion (eTICI 2b-3) during thrombectomy treatment of ischemic stroke leads to impr…
Tranexamic AcidBevacizumabAvastinTXAchronic subdural hematomas (cSDHs)Medtronic NeurovascularStryker NeurovascularRapid Medical
…OR ‘meningeal artery’) AND (Avastin OR Bevacizumab OR ‘TXA’ OR ‘Tranexamic Acid’ OR ‘medication adjunct’) AND (embolization). These criteria we…
LKWLKW-to-needleLKW-to-doorIVTacute ischemic strokeperipheral stroke centersanterior circulation large vessel occlusionintravenous thrombolysisanterior circulation stroke
…ior circulation stroke presenting to peripheral stroke centers, LKW to door appears to be the primary contributor to prolonged care…
ticagrelorAspirinprasugrelclopidogrelNIH Stroke Scaleintracranial aneurysmsinternal carotid artery (ICA) aneurysmsICA aneurysm
… (67.9%), clopidogrel (range 37.5-75 mg/day) in 33 (30.3%), and ticagrelor (range 90-180 mg/day) in 2 (1.8%) patients. Low-dose antiplatel…
tofacitinibulcerative colitischronic pouchitisCTNNHMRC
…tinib on clinical biomarkers and quality of life; and safety of tofacitinib use for treatment of chronic pouchitis. Study period is up to t…
B. coccoidesAcetateBlautia coccoidesmelanomamelanoma-bearing
…associated with non-progression. In melanoma-bearing mice, oral B. coccoides suppressed tumor growth and increased intratumoral effector CD8…
CAB-LAcabotegravirHIVANRS-PREVENIR
…persistence issues remain. Long-acting injectable cabotegravir (CAB-LA) is a promising new PrEP HIV prevention option. However, little…
osimertinibpelcitoclaxCohort 1Cohort 3NSCLCCohort 2
…cell lymphoma-2 (BCL-2)/BCL-extra-large (BCL-xL) inhibitor, and osimertinib in patients with EGFR-mutated advanced NSCLC.Methods Enrolled p…
tocilizumababataceptrituximabTNFirheumatoid arthritisRADANBIO
…1.38), TNFi 1.01 (0.66 to 1.54), rituximab 1.14 (0.71 to 1.84), tocilizumab 1.48 (0.92 to 2.40). LDA and remission rates were unaffected by…
OliceridinesufentanilNumeric Rating ScaleFirst Affiliated Hospital of Xi’an Jiaotong University
… associated with various opioid-related adverse events (ORAEs). Oliceridine, a novel G protein-biased ligand μ-opioid receptor agonist, has…